p. 603 - 608
(2011)p. 3492 - 3496
(2008)p. 269 - 274
(2019)p. 5449 - 5455
(2021/08/16)(2021/01/29)
p. 513 - 524
(2020/02/13)p. 293 - 296
(2017/07/11)p. 240 - 247
(2016/07/06)p. 4734 - 4737
(2016/09/28)p. 242 - 248
(2015/06/01)p. 1021 - 1027
(2011/09/20)p. 1092 - 1098
(2011/05/14)p. 2819 - 2822
(2012/01/02)p. 1123 - 1126
(2009/12/04)p. 1440 - 1447
(2010/03/24)p. 2871 - 2879
(2010/03/30)(2008/06/13)
p. 7403 - 7408
(2007/10/03)p. 1763 - 1766
(2007/10/03)p. 8769 - 8771
(2007/10/03)p. 2215 - 2225
(2007/10/03)p. 1847 - 1850
(2007/10/03)p. 1305 - 1307
(2007/10/03)p. 2957 - 2976
(2007/10/03)p. 702 - 706
(2007/10/03)p. 8123 - 8126
(2007/10/02)p. 401 - 404
(2007/10/02)p. 641 - 648
(2007/10/02)p. 1107 - 1108
(2007/10/02)p. 469 - 471
(2007/10/02)p. 1243 - 1250
(2007/10/02)p. 2604 - 2607
(2007/10/02)p. 983 - 990
(2007/10/02)p. 1190 - 1196
(2007/10/02)p. 3621 - 3624
(2007/10/02)(+)-Δ3-carene
pinane hydroperoxide
4β-chloro-3α,10α-epoxycarene
3-carene
(1R,6R)-3,7,7-trimethylbicyclo[4.1.0]hepta-3-ene